Via Falloppio, 61 - PADOVA
+39.049.8751435
+39.351.9617779
8.30-12.30 / 15.00-19.00
Sabato pomeriggio chiuso
LIBRERIA STUDIUM
Libreria medica internazionale
- PADOVA -
LIBRERIA STUDIUM
0,00 €
Clinical Applications of Nuclear Medicine Targeted Therapy
Bombardieri,Seregni, Evangelista, Chiesa, Chiti
Editore
Springer
Anno
2018
Pagine
503
ISBN
9783319630663
130,00 €
I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.

This book offers a practical and modern update on radioisotope therapy. Clinically oriented, it provides a thorough guide to patient management, with the latest indications and procedures for the current radioisotopic treatments. It addresses the clinical problems associated with each respective pathology, discussing the management of patients (diagnosis and non-radioisotope therapy), the radiopharmaceuticals available today, and the current radioisotopic procedures. Wherever possible, information on dosimetry is included at the end of each topic, together with a list of and comments on the most recent guidelines with their recommendations for radiometabolic therapy.

The book is divided into six main sections: thyroid diseases, hepatic tumors (HCC and hepatic metastases), bone metastases from prostate cancer, lymphomas, and neuroendocrine tumors. The last section is dedicated to new perspectives of radioisotope treatment. Based on contributions from of a multidisciplinary team of specialists: oncologists, surgeons, endocrinologists, hematologists, urologists, radiopharmacists and nuclear medicine physicians, it provides a comprehensive analysis of the position of radioisotope treatments among the various therapeutic options.

Readers interested in targeted therapy, radiometabolic therapy, radioimmunotherapy and radiometabolic imaging will find this book both informative and insightful.

Emilio Bombardieri graduated in Oncology and Nuclear Medicine at the University of Milan. In 1972 he joined the Istituto Nazionale Tumori, Milan, where he worked as a Nuclear Medicine Physician in the area of Oncology, Diagnosis and Therapy and later became Director of the Nuclear Medicine Division and Director of the Department of Diagnostic Imaging and Radiotherapy.In 2013 he was appointedScientific Director of Nuclear Medicine Division at Humanitas Gavazzeni Hospital and Coordinator of the Scientific Committee. Since 1982 he has been Professor of Physiology and Endocrinology at the Catholic University, ISEF, Milan. He served as President of the Italian Association of Nuclear Medicine (AIMN); he has chaired the EANM (European Association of Nuclear Medicine)Oncology Committee and was nominated President of the EANM Congress 2012 in Milan.


Ettore Seregni is the Head of the Nuclear Medicine Therapy and Endocrinology Unit at the IRCCS National Cancer Institute of Milan. His current research interests include the development and clinical validation of different radiopharmaceuticals for cancer therapy. His main fields of clinical research are neuroendocrine tumors, prostatic and thyroid cancer, and metastatic bone lesions.

Laura Evangelista is a nuclear medicine physician working at Veneto Institute of Oncology IOV – IRCCS in Padova, Italy. She worked as a research fellow at University “Federico II” of Napoli Italy, Memorial Sloan Kettering of New York City, USA and the Mayo Clinic of Rochester (Minnesota, USA) focusing on PET/CT in breast cancer, prostate cancer and molecular imaging. In 2009 she joined the Veneto Institute of Oncology, where she is currently pursuing a special interest in the nuclear diagnostic evaluation of cancer.

Carlo Chiesa 

Since October 2005, member of Dosimetry Committee of the European Association of Nuclear Medicine. Senior advisor member since 2013. From September 2006, coordinator of the of Italian Internal Dosimetry Group.
Teacher to IAEA dosimetry course in November 2013 & 2016, and EFOMP dosimetry course in 2016. In September 2016, IAEA expert mission to implement dosimetry in Kuwait City hospital.
From 2004 to the present, teacher of “Nuclear Medicine Equipment” at the postgraduate Nuclear Medicine School for physicians.
Consultant for Biocompatibles BTG L.t.d. for dosimetry and safety of Therasphere treatment of liver disease. In 2015, consultant of MedPace corelab (Cincinnati OHIO USA) for instrument validation in an international multicenter study.

Arturo Chiti graduated with a degree in Medicine and Surgery from the University of Milan and joined the Training Program in Nuclear Medicine at the University of Milan. He subsequently worked as Associate Chief at the National Cancer Institute in Milan, where he began his clinic and scientific experience in Oncology. He was appointed Full Professor in Diagnostic Imaging and Radiotherapy at the Humanitas University in Milan and is currently Director of the Training Program in Diagnostic Imaging at Humanitas University. He served as President of the European Association of Nuclear Medicine and has advised the International Atomic Energy Agency for many years, and his contributions have been recognized with an honorary membership in the European Society for Therapeutic Radiology and Oncology.

Table of contents (37 chapters)

 
  • Diagnosis and Treatment of Hyperthyroidism

    Testa, Rosa Miranda (et al.)

    Pages 3-17

  • Radiopharmaceuticals for Therapy of Thyroid Diseases

    Marzo, Katia

    Pages 19-23

  • Radioiodine Therapy of Hyperthyroidism

    Pepe, Giovanna (et al.)

    Pages 25-32

  • Dosimetry in the Radioiodine Treatment of Hyperthyroidism

    Canzi, Cristina (et al.)

    Pages 33-44

  • New Approaches in the Management of Thyroid Cancer

    Frangos, Savvas (et al.)

    Pages 45-58

  • Radioiodine Therapy of Thyroid Cancer

    Seregni, Ettore (et al.)

    Pages 59-68

  • Radioiodine Therapy of Thyroid Cancer Dosimetry

    Bianchi, Lorenzo

    Pages 69-76

  • Published Guidelines on Radioisotopic Treatments of Thyroid Diseases

    Setti, Lucia (et al.)

    Pages 77-92

  • Clinical Options for Treatment of Hepatocellular Carcinoma

    Virdis, Matteo (et al.)

    Pages 95-105

  • Medical Devices for Radioembolization

    Bogni, Anna (et al.)

    Pages 107-118

  • HCC Radioembolization with Yttrium-90 Glass Microspheres (TheraSphere)

    Maccauro, Marco (et al.)

    Pages 119-125

  • HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres)

    Rodari, Marcello (et al.)

    Pages 127-136

  • Dosimetry in the Treatment of Liver Malignancies with Microspheres

    Chiesa, Carlo

    Pages 137-152

  • The Clinical Challenge of Liver Metastasis

    Cappato, Stefano (et al.)

    Pages 153-163

  • Radioembolization of Hepatic Metastases with 90Y-Microspheres: Indications and Procedure

    Sciuto, Rosa (et al.)

    Pages 165-198

  • Guidelines on Radioisotope Treatment of Liver Cancer and Liver Metastases with Intra-arterial Radioactive Compounds

    Bozkurt, Murat Fani (et al.)

    Pages 199-203

  • Radiopharmaceuticals for Treatment of NETs

    Asti, Mattia (et al.)

    Pages 207-234

  • Paediatric Tumours of Neuroendocrine/Peripheral Neuroectodermal Origin

    Luksch, Roberto (et al.)

    Pages 235-251

  • Treatment with 131I-mIBG (Metaiodobenzylguanidine): Indications, Procedures, and Results

    Castellani, Maria Rita (et al.)

    Pages 253-271

  • Dosimetry for 131I mIBG Therapy

    Chiesa, Carlo (et al.)

    Pages 273-280

  • Medical Treatment of Gastroenteropancreatic (GEP) Neuroendocrine Tumors

    Carnaghi, Carlo (et al.)

    Pages 281-287

  • PRRT with Radiolabeled Peptides: Indications, Procedures, and Results

    Seregni, Ettore (et al.)

    Pages 289-295

  • Dosimetry in PRRT

    Cremonesi, Marta (et al.)

    Pages 297-313

  • Guidelines on Radioisotope Treatment of Neuroendocrine Tumors

    Caobelli, Federico (et al.)

    Pages 315-320

  • Bone Metastases in Prostate Cancer

    Bonomi, Maria (et al.)

    Pages 323-343

  • Radiopharmaceuticals for Bone Metastases

    Pagano, Benedetta (et al.)

    Pages 345-364

  • Targeted Therapy with Radium-223 of Bone Metastases

    Baldari, Sergio (et al.)

    Pages 365-377

  • Novel Approaches of Treatment with Radium-223 Targeted Therapy

    Ceresoli, Giovanni Luca (et al.)

    Pages 379-391

  • Dosimetry

    Pacilio, Massimiliano (et al.)

    Pages 393-403

  • Guidelines on Radioisotope Treatment of Bone Metastases in Prostate Cancer

    Murphy, Robert (et al.)

    Pages 405-413

  • Radioimmunotherapy of Lymphomas

    Luminari, Stefano (et al.)

    Pages 417-429

  • Radioimmunotherapy in the Transplant Setting

    Devizzi, Liliana

    Pages 431-441

  • Guidelines on Radioisotope Treatment of Lymphomas

    Cucinotta, Mariapaola (et al.)

    Pages 443-447

  • PSMA-Based Therapy of Metastasized Castrate-Resistant Prostate Cancer

    Schwarzenböck, Sarah Marie (et al.)

    Pages 451-464

  • Locoregional Treatment of Brain Tumors

    Kunikowska, Jolanta (et al.)

    Pages 465-473

  • CXCR4-Directed Endoradiotherapy as New Treatment Option in Advanced Multiple Myeloma

    Lapa, Constantin (et al.)

    Pages 475-481

     
  • Radiolabeled Somatostatin Analogues in the Treatment of Non-GEP-NET Tumors

    Versari, Annibale (et al.)

    Pages 483-503

 
 

 

Informazioni

Non ci sono recensioni

Dettaglio
Aggiungi la tua recensione

Ultimi prodotti